Coldstream Capital Management Inc Cytokinetics Inc Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,869 shares of CYTK stock, worth $105,206. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,869Holding current value
$105,206% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
410Shares Held
123MCall Options Held
3.23MPut Options Held
1.82M-
Black Rock Inc. New York, NY14.7MShares$538 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$435 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$365 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$293 Million0.06% of portfolio
-
State Street Corp Boston, MA6.17MShares$226 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.45B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...